Dolby Laboratories (DLB) Receivables - Other (2019 - 2026)

Dolby Laboratories (DLB) has reported Receivables - Other for 8 consecutive years, with $120.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other fell 15.14% year-over-year to $120.5 million; the trailing twelve-month figure through Jun 2026 stood at $120.5 million (down 15.14% YoY), and the FY2025 full-year result was $180.8 million, down 8.44% from the prior year.
• Receivables - Other declined to $120.5 million in Q2 2026 per DLB's latest filing, from $172.8 million in the prior quarter.
• Across five years, Receivables - Other topped out at $197.5 million in Q3 2024 and bottomed at $104.2 million in Q2 2022.
• Historically, Receivables - Other has averaged $148.8 million across 5 years, with a median of $145.1 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Receivables - Other jumped 31.68% in 2024, then retreated 15.14% in 2026.
• Over 5 years, Receivables - Other stood at $111.9 million in 2022, then advanced by 18.77% to $132.9 million in 2023, then soared by 31.68% to $175.0 million in 2024, then climbed by 1.71% to $178.0 million in 2025, then plunged by 32.3% to $120.5 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $120.5 million, $172.8 million, and $178.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.